Wearable system to monitor alcohol withdrawal in real time
Official title: Wearable Sensor System for Continuous Monitoring of Alcohol Withdrawal Syndrome
Funded at Creare, LLC · NIH-11313084 · Data updated 2026-11-12
A wearable bracelet collects physiological data to continuously monitor alcohol withdrawal severity and help clinicians intervene early for adults with alcohol use disorder.
Quick facts
| Grant type | Sbir 1 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Creare, LLC NIH-funded |
| Lab location | 1 site (Hanover, United States) |
| Project start | September 1, 2026 |
| Project end | February 28, 2027 |
| Funding year | 2026 |
| Award (this year) | $314,357 |
| NIH project number | 1R43AA032950-01 |
| Project ID | NIH-11313084 on NIH RePORTER |
Who could benefit from this research
✓Could help
Adults 21 years and older with Alcohol Use Disorder who are at risk for alcohol withdrawal.
✕Less likely to help
People without AUD or who are not at risk for withdrawal may not benefit from this monitoring approach.
What this research studies
This project develops a real-time wearable sensor system that tracks tremor, heart rate, heart rate variability, sleep, and sweat ethanol to measure alcohol withdrawal severity. A machine learning model turns these signals into a continuous AWS severity score that aligns with standard clinical thresholds. The system is designed to work with the Ria Health telehealth platform to support remote clinician oversight in outpatient care. The goal is to provide objective, passive monitoring that complements or replaces infrequent in-person assessments, potentially reducing complications and hospitalizations. The work is in its early phase and will focus on translating physiological signals into actionable care in real-world settings.
Why it matters
Potential benefit: If successful, patients could receive timely interventions that prevent severe withdrawal and improve outpatient management.
How similar studies have gone: Previous efforts show that wearable sensors can detect withdrawal-related signals, but continuous real-time AWS monitoring in outpatient settings is still emerging.
Where this research is happening
-
Creare, LLC
Hanover, United States Active
Researchers
- Principal investigator: Archambault-Leger, Veronique — Creare, LLC
- Study coordinator: Archambault-Leger, Veronique
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.